Print

PURE Bioscience (PURE) Reports 2013 Fiscal First Quarter Financial Results  
12/12/2012 9:37:31 AM

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2012.
//-->